Changes after publication

Changes after publication

October 2012: minor maintenance

January 2012: minor maintenance.

January 2011

Two corrections have been made to the full version of this guideline as well as to the NICE version and the Quick Reference Guide.

In the section Management of pregnancy with chronic hypertension 'and' has been changed to 'or' in the following recommendation (recommendation in the NICE version). It now reads:

Tell women who take angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs):

  • that there is an increased risk of congenital abnormalities if these drugs are taken during pregnancy

  • to discuss other antihypertensive treatment with the healthcare professional responsible for managing their hypertension, if they are planning pregnancy.

In addition, 'chlorothiazide diuretics' has been changed to 'chlorothiazide' in recommendations and in the NICE guideline and throughout the full guideline. These changes have been made on pages 4 and 8 of the Quick Reference Guide. Implementation tools have also been updated.

This web version of the NICE guideline incorporates these changes.

  • National Institute for Health and Care Excellence (NICE)